Manuel Bardiès on LinkedIn

Manuel Bardiès - Chercheur - INSERM - LinkedIn

Directeur de Recherches INSERM · Dr. Manuel Bardiès (Web Of Science Research ID: L-3136-2014) is working in Montpellier Institute for Cancer Research (IRCM) ...

Manuel Bardiès on LinkedIn: Welcome

EFOMP Policy Statement 19 on Dosimetry in Nuclear Medicine Therapy – Molecular Radiotherapy was approved by EFOMP 36 National Member ...

Manuel Bardiès on LinkedIn: Basic dosimetry and radiobiology for ...

Since 2001, he has been fully engaged at the Department of Molecular Biology and Genetics, serving as the head of the DNA Repair group at the ...

Manuel Bardiès' Post - European Cancer Organisation - LinkedIn

EFOMP Policy Statement n°19: Dosimetry in nuclear medicine therapy – Molecular radiotherapy is mentioned in https://lnkd.in/ej7kpxpB A big THANK YOU to the ...

Manuel Bardiès on LinkedIn: It's worth learning French just to attend ...

clap de fin du 2nd congrès de la SFBR 4 jours de très belles conférences, de discussions riches et de jolies rencontres!

Manuel Bardiès on LinkedIn: Superb!

Manuel Bardiès' Post ... Superb! View profile for Alex Ritter, graphic · Alex Ritter. Altos Labs Senior Scientist. 2y Edited.

Manuel Bardiès' Post - ecmp #efomp - LinkedIn

Nuclear Medicine dosimetry session at ECMP (Munich) this morning. Thank you to all speakers! Marta Cremonesi, Lidia Strigari, ...

Manuel Bardiès on LinkedIn: Webinar Series 2024

Topic: Radiobiology for radionuclide therapy & dosimetry During this Scientific Meeting, we will look into radiobiological effects of ...

Manuel Bardiès on LinkedIn: #sig_frid #nuclearmedicnedosimetry

So glad to have met again John Humm at the AAPM meeting in LA! I've been a fan for ... a long time! #SIG_FRID #NuclearMedicneDosimetry.

Manuel Bardiès on LinkedIn: Nuclear Medicine dosimetry at ECMP ...

Nuclear Medicine dosimetry at ECMP chaired by Lidia Strigari. Excellent talk by Marta Cremonesi. #ECMP #EFOMP Marta Cremonesi Lidia ...

Manuel Bardiès on LinkedIn: Dosimetry for Radiopharmaceutical ...

Medical Strategist focusing on Radiopharmaceuticals in Prostate & Rare Cancers. Forever an Educator & Advocate. 5mo.

Manuel Bardiès on LinkedIn: Very proud to have been part of the ...

Very proud to have been part of the "COST Action RATIONALE - an overview of challenges in radionuclide theranostics" session, during the ...

Manuel Bardiès' Post - efomp #aapm #iomp #iaea - LinkedIn

Last day, last session, last speaker… Thanks to all attendees, and thank you to the organisers. I'm very lucky to have attended that ...

Manuel Bardiès on LinkedIn: #sasnm

Thanks to Stuart M. and the South African colleague for their kind invitation to #SASNM Masterclass in Cape Town.

Manuel Bardiès on LinkedIn: Another SIG_FRID initiative Don't miss ...

The EFOMP Special Interest Group for Radionuclide Internal Dosimetry will host the next online Dosimetry Case Report meeting: Tuesday, ...

Manuel Bardiès posted on LinkedIn

Really enjoyed the #EANM22 conference in Barcelona! Proud to have presented on the necessity of dosimetry in molecular radiotherapy during ...

Manuel Bardiès on LinkedIn: #dosimetry #medicalphysics

Manuel Bardiès' Post · Dosimetry in radionuclide therapy: the clinical role of measuring radiation dose · More Relevant Posts.

Manuel Bardiès - nuclearmedicinedosimetry #opendose3d - LinkedIn

Very proud of my student Alex Vergara Gil who was awared today his PhD by University Paul Sabatier of Toulouse. Congrats Alex, and thank you ...

Manuel Bardiès on LinkedIn: Accuracy and uncertainty analysis of ...

Accuracy and uncertainty analysis of reduced time point imaging effect on time-integrated activity for 177Lu-DOTATATE PRRT in patients and ...

Manuel Bardiès on LinkedIn: Excellent occasion to discuss clinical ...